Creso Pharma’s initial public offer is set to raise around $5 million, the funds of which will be put towards developing its pharmaceutical grade cannabis and hemp-based products.
The company says its therapeutic products are delivered by effective controlled dosages, which can be used in both humans and pets.
The global market for medicinal cannabis is estimated to reach more than $260 billion dollars between 2015 and 2020.
Under the IPO offer shares will be issued at 20 cents each.
